407 results on '"Cilloniz, Catia"'
Search Results
2. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients
3. Pneumococcal Vaccination in Adults: What Can We Learn From Observational Studies That Evaluated PCV13 and PPV23 Effectiveness in the Same Population?
4. Validation of IDSA/ATS Guidelines for ICU Admission in Adults Over 80 Years Old With Community-Acquired Pneumonia
5. Machine-Learning Model for Mortality Prediction in Patients With Community-Acquired Pneumonia: Development and Validation Study
6. Early Recognition of Low-Risk SARS-CoV-2 Pneumonia: A Model Validated With Initial Data and Infectious Diseases Society of America/American Thoracic Society Minor Criteria
7. [Translated article] Biological Biomarkers in Respiratory Diseases
8. Biomarcadores biológicos en las enfermedades respiratorias
9. Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis
10. Ventilatory Support and Oxygen Therapy in the Elderly Palliative and End-of-Life Care Patients
11. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
12. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study
13. A review of the value of point-of-care testing for community-acquired pneumonia.
14. Aetiological diagnosis in new adult outpatients with bronchiectasis:role of predictors derived from real life experience
15. Neumonía adquirida en la comunidad. Normativa de la Sociedad Española de Neumología y Cirugía Torácica (SEPAR). Actualización 2020
16. A multicentre analysis of Nocardia pneumonia in Spain: 2010–2016
17. Viral Pneumonia: From Influenza to COVID-19
18. Pneumonia
19. Programmed ‘disarming’ of the neutrophil proteome reduces the magnitude of inflammation
20. Antimicrobial Resistance Among Streptococcus pneumoniae
21. Effect of Combined β-Lactam/Macrolide Therapy on Mortality According to the Microbial Etiology and Inflammatory Status of Patients With Community-Acquired Pneumonia
22. An international perspective on hospitalized patients with viral community-acquired pneumonia
23. Diabetes Mellitus and Pneumococcal Pneumonia.
24. Pneumococcal Serotypes Associated with Community-Acquired Pneumonia Hospitalizations in Adults in Spain, 2016–2020: The CAPA Study
25. World Pneumonia Day 2023: the rising global threat of pneumonia and what we must do about it
26. Clinical Outcomes of Critical COVID-19 in HIV-Infected Adults: A Propensity Score Matched Analysis
27. The pharmacokinetic evaluation of omadacycline (oral only dosing regimen) for the treatment of community-acquired bacterial pneumonia (CABP)
28. Bacteremia prediction in pneumococcal pneumonia: a comparative study of 2 scores
29. Community-Acquired Legionella Pneumonia in Human Immunodeficiency Virus–Infected Adult Patients : A Matched Case-Control Study
30. Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review
31. Management of pneumonia
32. Methods for preventing pneumonia
33. Introduction to pneumonia
34. Pathology and clinical features of pneumonia
35. Epidemiology, etiology, and risk factors of bacterial pneumonia
36. Diagnosis and classification of Pneumonia
37. The burden of PCV13 serotypes in hospitalized pneumococcal pneumonia in Spain using a novel urinary antigen detection test. CAPA study
38. The importance of airway and lung microbiome in the critically ill
39. Advances in molecular diagnostic tests for pneumonia
40. Community-acquired pneumonia severity assessment tools in patients hospitalized with COVID-19: a validation and clinical applicability study
41. Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study
42. A Novel Approach to Temperature Profiling in Relation to Clinical Outcomes in Oncological Patients with Neutropenia
43. Características clínicas y epidemiológicas de las muertes por dengue durante un brote en el norte del Perú
44. Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop Report
45. Community-Acquired Pneumonia Due to Multidrug- and Non–Multidrug-Resistant Pseudomonas aeruginosa
46. Interventions to improve outcomes in community-acquired pneumonia.
47. Advances in molecular diagnostic tests for community-acquired pneumonia
48. Hyperglycemia in Acute Critically Ill COVID-19 Patients
49. New antimicrobial approaches to gram positive respiratory infections
50. Differences between sexes concerning COVID-19-related pneumonia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.